Mutations in the KMT2D gene have been implicated in certain cancers, including medulloblastomas (Dhar et al., 2018), lymphomas (Zhang et al., 2015) and lung cancer (Alam et al., 2020). The gene discussed is KMT2D; the disease is lymphoma.